Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Croda confident after first-quarter sales growth

(Sharecast News) - Croda International reported an 8% rise in first-quarter sales to £442m on Wednesday - up 9% at constant currency, as higher volumes offset prior year price and mix headwinds. The FTSE 100 specialty company said all three of its business segments - consumer care, life sciences and industrial specialties - posted growth, with the company maintaining its full-year profit outlook.

Consumer care led the quarter with sales of £255m, up 8% both reported and in constant currency, supported by strong local customer demand and robust performance in fragrances and flavours.

Beauty care and home care posted mid-single digit gains, while beauty actives declined slightly year-on-year but recovered strongly from the fourth quarter of 2024.

Life sciences recorded a 10% increase in reported sales to £134m, or 11% at constant currency, driven by solid growth in crop protection and seed enhancement.

Pharma sales also improved year-on-year and sequentially, with biopharma gains outweighing continued softness in consumer health and veterinary markets.

Industrial specialties contributed £53m in sales - a 6% increase on a reported basis and 7% at constant currency, also supported by volume growth.

Improved utilisation across Croda's 11 shared manufacturing sites helped drive operational efficiencies.

The group said adjusted profit before tax was in line with expectations and reiterated its 2025 forecast of £265m to £295m at constant currency.

Croda noted progress across its five-point plan to enhance financial performance, including customer engagement, innovation commercialisation, and cost base realignment.

While the company acknowledged increased geopolitical uncertainty and the introduction of global trade tariffs, it said its localised manufacturing and procurement strategy provided insulation, adding that it was assessing the impact with plans to apply a tariff surcharge if needed.

At 0812 BST, shares in Croda International were up 8% at 2,943p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.